| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.15B | 57.42B | 53.86B | 31.82B | 24.39B | 23.23B |
| Gross Profit | 24.73B | 26.69B | 24.98B | 14.51B | 10.14B | 9.50B |
| EBITDA | 11.85B | 13.19B | 13.67B | 5.75B | 3.07B | 2.96B |
| Net Income | 6.27B | 7.73B | 8.46B | 2.93B | 1.23B | 612.64M |
Balance Sheet | ||||||
| Total Assets | 57.72B | 57.29B | 59.31B | 48.33B | 41.52B | 41.41B |
| Cash, Cash Equivalents and Short-Term Investments | 17.45B | 16.96B | 20.43B | 17.42B | 16.58B | 16.24B |
| Total Debt | 0.00 | 0.00 | 464.00K | 2.00B | 2.00B | 3.00B |
| Total Liabilities | 11.02B | 12.00B | 18.59B | 14.93B | 10.38B | 10.74B |
| Stockholders Equity | 46.70B | 45.29B | 40.72B | 33.40B | 31.14B | 30.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.08B | 6.30B | 1.94B | 2.28B | 2.22B |
| Operating Cash Flow | 0.00 | 7.67B | 8.43B | 2.98B | 3.22B | 3.40B |
| Investing Cash Flow | 0.00 | -7.85B | -1.73B | -1.98B | -564.73M | -2.24B |
| Financing Cash Flow | 0.00 | -3.30B | -3.18B | -666.28M | -1.81B | -891.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥36.61B | 5.10 | ― | 3.79% | -9.87% | -30.64% | |
76 Outperform | ¥148.53B | 22.89 | ― | 1.92% | 7.46% | -8.01% | |
75 Outperform | ¥59.10B | 6.56 | ― | 2.03% | -13.53% | 173.43% | |
67 Neutral | ¥662.38B | 9.47 | 6.07% | 3.69% | 0.48% | 6.92% | |
67 Neutral | ¥86.95B | 11.91 | ― | 4.76% | 1.81% | 9.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥157.51B | 33.83 | -6.21% | 1.61% | -4.91% | -136.94% |